About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | DMT210 Topical Gel in the Treatment of Atopic Dermatitis

DMT210 Topical Gel in the Treatment of Atopic Dermatitis

NCT02949960·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Dermata Therapeutics

Age

12–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Male or female 12 years or older
Patient has chronic, stable AD that has been present for at least 3 months with 5-35% (inclusive) BSA (Body Surface Area) of AD involvement
Patient has two analogous, Target Lesions; one lesion within each of the two Treatment Areas
Patient is willing and able to comply with the protocol

You may not be if

Patient has used topical therapies for AD within the Treatment Areas 2 weeks before baseline

The record

StatusCompleted

PhasePhase 2

Taking part19

StartedOct 2016

UpdatedApr 18, 2018

Conditions

Atopic Dermatitis

Where2

Dermata Investigational Site
Houston, Texas, United States
Dermata Investigational Site
Norfolk, Virginia, United States